Atypical Localized Scleroderma Development During Nivolumab Therapy for Metastatic Lung Adenocarcinoma

Cutis. 2022 Oct;110(4):E11-E13. doi: 10.12788/cutis.0637.

Authors

Emma Fixsen¹, Jigar Patel¹, Meenal Kheterpal¹

Affiliation

¹ Dr. Fixsen is from the University of Hawaii Internal Medicine Residency Program, Honolulu. Drs. Patel and Kheterpal are from the Department of Dermatology, Duke University, Durham, North Carolina.

PMID: 36446107
DOI: 10.12788/cutis.0637

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma of Lung* / drug therapy
Humans
Lung Neoplasms* / drug therapy
Nivolumab / adverse effects
Scleroderma, Localized*

Substances

Nivolumab